https://dtrf.org/about-dtrf/news-updates/fda-approves-ogsiveo-nirogacestat-as-the-first-medical-therapy-for-the-treatment-of-adults-with-desmoid-tumors/
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH...
Dec 4, 2023 - (Pittsburgh, PA) – November 27, 2023 – The U.S. Food and Drug Administration (FDA) announced approval today of OGSIVEO (nirogacestat) for the treatment of...
the firstmedical therapyfdanirogacestattreatment
https://www.cancer.gov/news-events/cancer-currents-blog/2023/nirogacestat-shrinks-desmoid-tumors
Nirogacestat Shrinks Desmoid Tumors - NCI
In a small clinical trial, the investigational drug nirogacestat shrank tumors in 40% of people with desmoid tumors and led to substantial improvements in pain...
desmoid tumorsnirogacestatshrinksnci